Skip to main content
Clinical Trials/NCT02176603
NCT02176603CompletedNot Applicable

Observational, Investigator Initiated, Monocentric Study of the Endothelial Dysfunction in Adolescent and Adult Patients With Phenylketonuria Due to Phenylalanine Hydroxylase Deficiency

Charite University, Berlin, Germany0 sites51 target enrollmentStarted: May 2014Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
51
Primary Endpoint
Post-ischaemic venous flow (measured in ml/min) in patients with PKU compared to healthy volunteers

Study Overview

Brief Summary

The purpose of this study is to determine whether adolescent and adult patients with phenylketonuria who are on long-term phenylalanine-restricted diet suffer from endothelial dysfunction.

Detailed Description

The aim of the study is the examination of endothelial dysfunction and oxidative stress markers in adolescent and adult patients with phenylketonuria (PKU), in correlation to phenylalanine values und phenylalanine-restricted diet. 25-50 patients with PKU aged ≥16 years of age and a control group of 25 age- and sex-matched healthy volunteers will be included in the study.

Endothelial dysfunction will be measured by venous occlusion plethysmography on the lower legs in the PKU patients and in the control group. Wave velocity, aortic stiffness, and intima media thickness of the common carotid artery will be measured by vicorder and duplex ultrasound scanner in the PKU patients and in the control group. Analyses of phenylalanine metabolites and renal function will be performed only in the PKU patients, analyses of oxidative stress markers in the PKU patients and in the control group. Dietary protocols of the patients with PKU will be calculated for their daily phenylalanine, total protein, and calorie intake. Results of the study will be kept in the medical records and paper case report forms. Data will be analyzed only in pseudonymized form.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
16 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • phenylketonuria due to phenylalanine hydroxylase deficiency
  • age ≥16 years

Exclusion Criteria

  • age <16 years
  • pregnancy or maternity
  • late-treated phenylketonuria
  • phenylketonuria due a defect in BH4 synthesis or BH4 regeneration

Outcomes

Primary Outcomes

Post-ischaemic venous flow (measured in ml/min) in patients with PKU compared to healthy volunteers

Time Frame: 18 months

Secondary Outcomes

  • Aortic pulse wave velocity in patients with PKU compared to healthy volunteers. Intima media thickness in patients with PKU compared to healthy volunteers.(18 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Uwe Querfeld

Prof. Dr.

Charite University, Berlin, Germany

Similar Trials

Observational Study of Endothelial... | Clinical Trial